Isoniazid
Back to searchMolecule Structure
Scientific Name
Isoniazid
Description of the Drug
Isoniazid is an antibiotic used to treat mycobacterial infections; most commonly use in combination with other antimycobacterial agents for the treatment of active or latent tuberculosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00951
http://www.drugbank.ca/drugs/DB00951
Brand Name(s)
Dow-isoniazid, Hyzyd, Isoniazid, Laniazid, Nicotibine, Nydrazid, Rimifon, Stanozide
Company Owner(s)
Thepharmanetwork Llc, Sun Pharmaceutical Industries Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Cmp Pharma Inc, Nexgen Pharma Inc, Purepac Pharmaceutical Co, Novartis Pharmaceuticals Corp, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Enoyl-[acyl-carrier-protein] reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL1849 |
Clinical Trial(s)
Unichem Links
| Atlas | isoniazid | |||||||||
| SureChEMBL | SCHEMBL228 | |||||||||
| PharmGKB | PA450112 | |||||||||
| Human Metabolome Database | HMDB0015086 | |||||||||
| DrugBank | DB00951 | |||||||||
| PubChem: Thomson Pharma | 15321438 | |||||||||
| PubChem | 3767 | |||||||||
| Mcule | MCULE-6324947959 | |||||||||
| NMRShiftDB | 20097187 | |||||||||
| LINCS | LSM-6682 | LSM-46042 | ||||||||
| Nikkaji | J1.371D | |||||||||
| PDBe | NIZ | |||||||||
| BindingDB | 50336507 | |||||||||
| EPA CompTox Dashboard | DTXSID8020755 | |||||||||
| DrugCentral | 1497 | |||||||||
| Brenda | 208021 | 93732 | 93730 | 51707 | 2409 | 44273 | 851 | 10677 | 93729 | 10678 |
| ChemicalBook | CB5102053 | |||||||||
| rxnorm | ISONIAZID | |||||||||
| PubChem: Drugs of the Future | 92309394 | |||||||||
| KEGG Ligand | C07054 | |||||||||
| ChEBI | 6030 | |||||||||
| ZINC | ZINC000000001590 |
